Search Results

Capecitabine dominant over fluorouracil/levofolinate in Japan

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 586, 2009-09-05 , pp. 6-6(1)

Publisher: Adis International

A personal touch - the value of guided treatment in cancer care

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 580, 2009-06-13 , pp. 7-8(2)

Publisher: Adis International

Imatinib/interferon: Colon cancer in elderly patients: 2 case reports

Source: Reactions, Volume 1, Number 1238, 2009-02-07 , pp. 18-19(2)

Publisher: Adis International

Chorionic gonadotropin/leuprorelin/menotropin: First report of fatal colon cancer?: case report

Source: Reactions, Volume 1, Number 1229, 2008-11-22 , pp. 9-10(2)

Publisher: Adis International

A phase III trial (NSABP C-08) of adjuvant bevacizumab for colon cancer will continue as planned.

Source: Inpharma, Volume 1, Number 1661, 2008-10-25 , pp. 6-6(1)

Publisher: Adis International

Palliative chemotherapy increases survival in metastatic colon cancer

Source: Inpharma, Volume 1, Number 1659, 2008-10-11 , pp. 20-20(1)

Publisher: Adis International

Palliative chemotherapy increases survival in metastatic colon cancer

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 564, 2008-10-18 , pp. 8-8(1)

Publisher: Adis International

Bevacizumab benefits abound for patients with mCRC

Source: Inpharma, Volume 1, Number 1656, 2008-09-20 , pp. 13-13(1)

Publisher: Adis International

Capecitabine dominant in Dukes' C colon cancer

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 563, 2008-10-04 , pp. 5-5(1)

Publisher: Adis International

Capecitabine dominant in Dukes' C colon cancer

Source: Inpharma, Volume 1, Number 1658, 2008-10-04 , pp. 3-3(1)

Publisher: Adis International

Cetuximab [Erbitux; Merck] receives EU approval for broader use in colon cancer.

Source: Inpharma, Volume 1, Number 1649, 2008-08-02 , pp. 21-21(1)

Publisher: Adis International

Capecitabine effective in colon cancer management

Source: Inpharma, Volume 1, Number 1646, 2008-07-12 , pp. 15-15(1)

Publisher: Adis International

Detection of Parvovirus B19 Nucleic Acids and Expression of Viral VP1/VP2 Antigen in Human Colon Carcinoma

Authors: Li, Yuanfei; Wang, Juanhong; Zhu, Guoqiang; Zhang, Xi; Zhai, Huihong; Zhang, Weiping; Wang, Wenqing; Huang, Gaosheng

Source: The American Journal of Gastroenterology, Volume 102, Number 7, July 2007 , pp. 1489-1498(10)

Publisher: Blackwell Publishing

A matched, case–control study of the association between Schistosoma japonicum and liver and colon cancers, in rural China

Authors: D.-C. Qiu; A.E. Hubbard; B. Zhong; Y. Zhang; R.C. Spear

Source: Annals of Tropical Medicine and Parasitology, Volume 99, Number 1, January 2005 , pp. 47-52(6)

Publisher: Maney Publishing

Induction of macroautophagy in human colon cancer cells by soybean B-group triterpenoid saponins

Authors: Ellington, Allison A.; Berhow, Mark; Singletary, Keith W.

Source: Carcinogenesis, Volume 26, Number 1, 1 January 2005 , pp. 159-167(9)

Publisher: Oxford University Press

Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention

Author: Chan T.A.

Source: Lancet Oncology, Volume 3, Number 3, 1 March 2002 , pp. 166-174(9)

Publisher: Elsevier

Expression Profile Analysis of Colon Cancer Cells in Response to Sulindac or Aspirin

Authors: Iizaka M.; Furukawa Y.; Tsunoda T.; Akashi H.; Ogawa M.; Nakamura Y.

Source: Biochemical and Biophysical Research Communications, Volume 292, Number 2, March 2002 , pp. 498-512(15)

Publisher: Academic Press

Folic-acid-mediated inhibition of human colon-cancer cell growth

Author: Duthie S.J.

Source: Nutrition, Volume 17, Number 9, September 2001 , pp. 736-737(2)

Publisher: Elsevier

Folate and chemoprevention of colorectal cancer: is 5-methyl-tetrahydrofolate an active antiproliferative agent in folate-treated colon-cancer cells?

Authors: Akoglu B.; Faust D.; Milovic V.; Stein J.

Source: Nutrition, Volume 17, Number 7, July 2001 , pp. 652-653(2)

Publisher: Elsevier

Video helps colon-cancer screening uptake

Author: Sansom C.

Source: Lancet Oncology, Volume 2, Number 1, 1 January 2001 , pp. 2-2(1)

Publisher: Elsevier